Scientists develop "smart insulin" for type 1 diabetes, potentially reducing injections from daily to weekly.

Scientists have developed a revolutionary "smart insulin" for type 1 diabetes patients, mimicking natural blood sugar fluctuations and potentially reducing injections from 10 times daily to once a week. Funded projects aim to create glucose-responsive insulins (GRIs) that activate in response to blood sugar levels, helping manage glycemic control and avoiding hypoglycemia. This advancement could significantly improve treatment for millions of patients worldwide.

August 11, 2024
4 Articles